Skip to main content
VET
NYSE Energy & Transportation

Vermilion Posts C$35M Q3 Loss on Non-Cash Hedges, Sets 2027 Budget and 4% Dividend Hike

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Oil & Gas Stocks · Energy
Sentiment info
Neutral
Importance info
7
Price
$10.691
Mkt Cap
$1.635B
52W Low
$7.22
52W High
$14.82
52W Position info
48% above low
Off High info
28% below high
Rel. Volume info
2.2× avg
Market data snapshot near publication time

VET sits 48% above its 52-week low of $7.22 on elevated volume (2.2× avg).

Summary

Vermilion's Q3 net loss of C$35 million was driven by C$245 million of non-cash hedge mark-to-market losses, while FFO of C$237 million funded capital and cut net debt to C$1.17 billion. It also set a C$675-725 million 2027 budget, 122,000-126,000 boe/d guidance and a planned 4% dividend increase to C$0.14 per quarter.


Key Events · Earnings and Guidance · VET

  • Q3 Loss Is Non-Cash Hedge Mark-to-Market

    Net loss of C$35 million (C$0.23/basic share) versus C$2.6 million profit a year earlier, driven by C$245 million of unrealized derivative losses (C$188 million net of tax) as forward oil and European gas prices rose.

  • Cash Generation and Debt Reduction

    FFO of C$237 million (C$1.55/basic share) and free cash flow over C$90 million funded C$146 million of E&D capital; net debt fell about C$60 million to C$1.17 billion, down roughly C$900 million over 18 months.

  • 2027 Budget and Production Guidance

    Board approved C$675-725 million of 2027 E&D capital with production of 122,000-126,000 boe/d, about 2% absolute and 5% per-share growth; C$150 million of the spend adds production starting 2028.

  • Dividend to Rise 4% in 2027

    Targeting a quarterly dividend of C$0.14 per share (C$0.56 annualized) effective with the Q1 2027 payment on March 31, 2027, subject to board approval in March 2027; current quarterly dividend is C$0.135.


Analysis · VET · Energy & Transportation

The headline loss is an accounting artifact, not a cash problem. C$245 million of unrealized mark-to-market losses on hedges (C$188 million after tax) pushed Q3 to a C$35 million net loss, but those losses exist because forward oil and European gas prices rose, which improves future revenue. Cash generation was solid at C$237 million of FFO and over C$90 million of free cash flow, funding C$146 million of capital spending while net debt fell about C$60 million to C$1.17 billion. The genuinely new information is forward-looking: a 2027 capital budget of C$675-725 million, production guidance of 122,000-126,000 boe/d, and a planned 4% dividend increase to C$0.14 per quarter (C$0.56 annualized) payable March 31, 2027, subject to board approval in March 2027. The main negative is timing — the Montney 28,000 boe/d target slips to early 2029 from mid-2028 on third-party processing delays, with capital reallocated to the Deep Basin.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, VET was trading at $10.69 on NYSE in the Energy & Transportation sector, with a market capitalization of approximately $1.6B. The 52-week trading range was $7.22 to $14.82. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

VET - Latest Insights

VET
Nov 04, 2026, 11:42 AM EST
Source: Seeking Alpha
Importance Score:
7
Price at Filing: $10.86
Real-time Price: $10.20 info
Change: -$0.655 (-6%) info
Market Cap: $1.573B info
VET
Jul 29, 2026, 7:33 PM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $10.96
Real-time Price: $10.20 info
Change: -$0.760 (-7%) info
Market Cap: $1.573B info
VET
Jul 29, 2026, 7:32 PM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $10.96
Real-time Price: $10.20 info
Change: -$0.760 (-7%) info
Market Cap: $1.573B info
VET
Jul 29, 2026, 5:01 PM EDT
Source: PR Newswire
Importance Score:
8
Price at Filing: $10.87
Real-time Price: $10.20 info
Change: -$0.670 (-6%) info
Market Cap: $1.573B info
VET
May 06, 2026, 9:06 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $12.78
Real-time Price: $10.20 info
Change: -$2.58 (-20%) info
Market Cap: $1.573B info